15-month efficacy of maternal oral zidovudine to decrease vertical transmission of HIV-1 in breastfed African children
Authors:
- F DabisFDF Dabis
- L Dequae-MerchadouLDL Dequae-Merchadou
- V LeroyVLV Leroy
- L MandelbrotLML Mandelbrot
- C Welffens-EkraCWC Welffens-Ekra
- 1 December 1999
- journal article
- Published by Elsevier in The Lancet
- Vol. 354 (9195) , 2050-2051
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999
- 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trialThe Lancet, 1999
- International multicentre pooled analysis of late postnatal mother-to-child transmission of HIV-1 infectionThe Lancet, 1998